Zevra Therapeutics
ZVRA
ZVRA
70 hedge funds and large institutions have $404M invested in Zevra Therapeutics in 2022 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 17 increasing their positions, 22 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
2.25% less ownership
Funds ownership: 19.41% → 17.16% (-2.2%)
23% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 22
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
70
Holding in Top 10
1
Calls
$4.05M
Puts
$4.11M
Top Buyers
| 1 | +$17.1M | |
| 2 | +$500K | |
| 3 | +$349K | |
| 4 |
Citigroup
New York
|
+$311K |
| 5 |
Jane Street
New York
|
+$147K |
Top Sellers
| 1 | -$1.93M | |
| 2 | -$1.12M | |
| 3 | -$820K | |
| 4 |
E
Ergoteles
New York
|
-$484K |
| 5 |
Millennium Management
New York
|
-$348K |